These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Common clinicopathological features in late-onset hereditary transthyretin amyloidosis (Ala97Gly, Val94Gly and Val30Met). Koike H; Nakamura T; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Yasuda T; Mukai E; Date Y; Shiomi K; Nakazato M; Katsuno M; Sobue G Amyloid; 2019; 26(sup1):24-25. PubMed ID: 31343348 [No Abstract] [Full Text] [Related]
8. Cardiac findings and events observed in an open-label clinical trial of tafamidis in patients with non-Val30Met and non-Val122Ile hereditary transthyretin amyloidosis. Damy T; Judge DP; Kristen AV; Berthet K; Li H; Aarts J J Cardiovasc Transl Res; 2015 Mar; 8(2):117-27. PubMed ID: 25743445 [TBL] [Abstract][Full Text] [Related]
9. Cardiovascular autonomic functions in late-onset hereditary transthyretin amyloidosis with Val30Met mutation. Nakamura T; Koike H; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G Amyloid; 2019; 26(sup1):6. PubMed ID: 31343341 [No Abstract] [Full Text] [Related]
10. A case report of osteoarthritis associated with hereditary transthyretin amyloidosis ATTRV30M. Anan I; Bång J; Lundgren HE; Wixner J; Westermark P Amyloid; 2019; 26(sup1):29-30. PubMed ID: 31343355 [No Abstract] [Full Text] [Related]
11. Reduced intraepidermal nerve fibre density in patients with hereditary transthyretin amyloidosis. Masuda T; Ueda M; Misumi Y; Nomura T; Inoue Y; Isoguchi A; Kanenawa K; Tasaki M; Yamashita T; Sonoda Y; Obayashi K; Ando Y Amyloid; 2019; 26(sup1):79-80. PubMed ID: 31343297 [No Abstract] [Full Text] [Related]
12. Changes in nerve excitability indices in hereditary transthyretin amyloidosis. Yamashita T; Ueda M; Misawa S; Inoue Y; Masuda T; Misumi Y; Takamatsu K; Obayashi K; Kuwabara S; Ando Y Amyloid; 2019; 26(sup1):9-10. PubMed ID: 31343340 [No Abstract] [Full Text] [Related]
13. Early diagnostic tools in hereditary amyloidosis related to transthyretin (hATTR) V30M autonomic neuropathy. de Campos CF; Conceição I; Castro I Amyloid; 2019; 26(sup1):35-36. PubMed ID: 31343294 [No Abstract] [Full Text] [Related]
14. Autonomic dysfunction as first presentation of Glu54Gln transthyretin amyloidosis. Fortuna A; Salvalaggio A; Cipriani A; Cacciavillani M; De Conti G; Pilichou K; Frizziero L; Cecchin D; Briani C J Neurol Sci; 2022 Jun; 437():120264. PubMed ID: 35460948 [No Abstract] [Full Text] [Related]
15. Unexplained cardiac failure leading to the identification of a Belgian family affected by hereditary amyloidosis. De Pasqual A; Biessaux Y; Blettard N; Crémers S; Caers J Acta Clin Belg; 2013; 68(4):303-5. PubMed ID: 24455802 [TBL] [Abstract][Full Text] [Related]
16. Cardiac involvement, morbidity and mortality in hereditary transthyretin amyloidosis because of p.Glu89Gln mutation. Gospodinova M; Sarafov S; Chamova T; Kirov A; Todorov T; Nakov R; Todorova A; Denchev S; Tournev I J Cardiovasc Med (Hagerstown); 2020 Sep; 21(9):688-695. PubMed ID: 32740500 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of mutant ATTR cardiac amyloidosis in elderly African Americans with heart failure. Arvanitis M; Chan GG; Jacobson DR; Berk JL; Connors LH; Ruberg FL Amyloid; 2017 Dec; 24(4):253-255. PubMed ID: 29052438 [No Abstract] [Full Text] [Related]
18. Hereditary transthyretin amyloidosis associated with a transthyretin variant Thr59Arg. Watanabe T; Obayashi K; Misumi Y; Tasaki M; Shinriki S; Ando T; Akagami T; Ueda M; Yamashita T; Hirotani S; Ando Y Amyloid; 2017 Mar; 24(sup1):119. PubMed ID: 28434332 [No Abstract] [Full Text] [Related]
19. Hereditary amyloid neuropathy by transthyretin Val107 mutation in a patient of African origin. Cassereau J; Lavigne C; Letournel F; Ghali A; Verny C; Dubas F; Devière F; Nicolas G J Peripher Nerv Syst; 2008 Sep; 13(3):251-4. PubMed ID: 18844793 [No Abstract] [Full Text] [Related]